9th Masterclass in Clinical Oncology for Residents of Oncologic Specialties: Workshops and Case Presentations – University of Ioannina
Oesophageal cancer: exploring controversies overview of experts' opinions of Austria, Germany, France, Netherlands and Switzerland – topic of research paper in Clinical medicine. Download scholarly article PDF and read for free on
International Journal of Colorectal Disease | Volume 32, issue 1
Methods in Clinical Cancer Research (MCCR) 2021 | ESMO
SAKK Swiss Group for Clinical Cancer Research Overview | SignalHire Company Profile
SAKK | BIG against breast cancer
Home | SAKK
Swiss Medical Weekly - Update Swiss guideline for counselling and testing for predisposition to breast, ovarian, pancreatic and prostate cancer
Indication Lymphome agressif à cellules B récidivant ou ... - CHUV
Patient-reported outcomes of patients with advanced biliary tract cancers receiving gemcitabine plus capecitabine: a multicenter, phase II trial of the Swiss Group for Clinical Cancer Research. | Semantic Scholar
Francesco Bertoni has been elected as President of the Lymphoma Project Group of Swiss Group for Clinical Cancer Research
Home | SAKK
SAKK Swiss Group for Clinical Cancer Research | LinkedIn
SAKK on Twitter: "Hans Rudolf Keller is the new CEO of SAKK The Board of the Swiss Group for Clinical Cancer Research (SAKK) has elected Hans Ru- dolf Keller as its new
BIG Members | Breast International Group
SCTO Platforms - scto
Swiss Group for Clinical Cancer Research (SAKK) – Life Science Zurich Business Network
Tweets with replies by SAKK (@SAKK_ch) / Twitter
Patient-reported outcomes of patients with advanced biliary tract cancers receiving gemcitabine plus capecitabine: a multicenter, phase II trial of the Swiss Group for Clinical Cancer Research. | Semantic Scholar
CAREFOR, The Clinical Academic Cancer Research Forum
Talidox | InnoMedica
Radiotherapy to the primary tumour for newly diagnosed, metastatic prostate cancer (STAMPEDE): a randomised controlled phase 3 trial - The Lancet
